Highlights Allergy Therapeutics plc

Equities

AGY

GB00B02LCQ05

Delayed London S.E. Other stock markets 03:30:11 2024-05-02 am EDT			5-day change	1st Jan Change
2.9 ^GBX	+0.87%		+3.57%	+16.00%

Apr. 03	Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director	CI
Mar. 27	Allergy Therapeutics Gets OK to Draw Down GBP15 Million From Amended Loan Facility	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line	Mar. 27	AN
Earnings Flash (AGY.L) ALLERGY THERAPEUTICS Reports Fiscal H1 Revenue GBP33.6M	Mar. 27	MT
Earnings Flash (AGY.L) ALLERGY THERAPEUTICS Posts Fiscal H1 Loss GBX-0.58	Mar. 27	MT
Allergy Therapeutics plc Provides Sales Guidance for the Second Half and Full Year Ending on 30 June 2024	Mar. 27	CI
Allergy Therapeutics plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 27	CI
Allergy Therapeutics Announces Commencement of Subcutaneous Dosing of Peanut Allergic Patients in the Phase I/IIa PROTECT Trial Evaluating its Novel Virus-Like Particle Based Peanut Allergy Vaccine Candidate	Mar. 12	CI
Allergy Therapeutics forecasts revenue drop but trials going well	Feb. 14	AN
Alliance Pharma appoints chair; FireAngel sales down	Feb. 05	AN
Allergy Therapeutics resumes trading on AIM; annual revenue plunges	Jan. 30	AN
Allergy Therapeutics amends facility, plans warrant issue	Dec. 27	AN
EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens	Dec. 15	AN
AIM WINNERS & LOSERS: Impellam climbs on GBP483 million takeover offer	Dec. 13	AN
Allergy Therapeutics plc Provides an Update on the Data Analysis of Its Pivotal G306 Phase III Trial of Grass MATA MPL	Dec. 13	CI
Allergy Therapeutics in Advanced Talks for Potential Funding; Shares Drop	Dec. 11	MT
Allergy Therapeutics stock falls on lower sales outlook	Dec. 11	AN
Allergy Therapeutics plc Announces Interim Top Line Results from its Pivotal G306 Phase III Trial of Grass MATA MPL	Nov. 14	CI
ZQ Raises Holding in Allergy Therapeutics to 65% After Offer Closure	Nov. 10	MT
SkyGem to Launch Mandatory Cash Bid for Remaining Allergy Therapeutics Shares	23-10-16	MT
ZQ makes mandatory offer for Allergy Therapeutics as holding hits 60%	23-10-16	AN
Allergy Therapeutics raises GBP40.8 million in fundraise	23-10-13	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Allergy Therapeutics plc

Equities

AGY

GB00B02LCQ05

Highlights

Filters